Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $332.71 | $7.29 | 4,463.61% | 6,654.20x | 319.88x | 7.37x | 8.92x | 17.79x | $529.27M | 1.44% | $4.13B | 37.48 | $34.72B | 109.18 | ||
| CORT | CORCEPT THERAPEUTICS INC | $77.71 | $32.74 | 137.36% | 77.71x | 76.37x | 10.86x | 12.94x | 1.08x | $162.57M | 2.02% | $631.90M | 6.10 | $8.06B | 122.09 | ||
| NVO | NOVO NORDISK A S | $44.97 | $151.69 | -70.35% | 12.51x | 1.88x | 4.11x | 7.63x | 0.13x | $9.34B | 4.67% | $26.18B | 5.89 | $210.48B | 8.48 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.65 | $11.33 | -23.65% | 18.02x | 7.05x | 5.74x | 3.66x | 0.38x | -$23.64M | -4.89% | $133.17M | 2.38 | $495.25M | 7.37 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.75 | $5.01 | -65.06% | 25.00x | 13.33x | 2.24x | 2.66x | 0.14x | -$11.69M | -8.40% | $52.91M | 0.67 | $135.27M | 15.25 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $434.23 | $29.07 | 1,393.90% | 1,400.74x | 298.26x | 17.78x | 245.27x | 5.96x | $221.36M | 0.39% | $233.89M | 1.78 | $59.09B | 388.95 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $41.97 | $15.16 | 176.93% | 85.65x | 39.66x | 5.24x | 5.94x | 1.28x | $101.73M | 3.25% | $535.38M | 7.17 | $3.02B | 56.29 | ||
| GMAB | GENMAB A | $30.82 | $114.88 | -73.17% | 13.15x | 1.78x | 5.55x | 3.44x | 0.11x | $1.19B | 6.04% | $5.75B | 8.96 | $18.17B | 9.08 | ||
| ARGX | ARGENX SE | $906.74 | $258.61 | 250.61% | 36.23x | 54.19x | 29,249.68x | 7.72x | 3.03x | $467.72M | 0.85% | $7.17B | 117.50 | $52.94B | 65.25 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $206.89 | $61.67 | 235.50% | 89.56x | 29.55x | 16.12x | 4.29x | 1.61x | $30.76M | 0.76% | $950.17M | 48.53 | $4.38B | 42.55 | ||
| TECH | BIO-TECHNE CORP | $63.49 | $16.50 | 284.83% | 126.98x | 31.07x | 8.11x | 5.03x | 1.75x | $224.06M | 2.27% | $1.97B | 12.65 | $10.14B | 45.91 | ||
| RPRX | ROYALTY PHARMA PLC | $39.75 | $41.82 | -4.94% | 22.59x | 8.67x | 7.31x | 2.38x | 0.47x | $2.11B | 12.30% | $9.62B | 22.28 | $30.95B | 29.64 | ||
| VCEL | VERICEL CORP | $38.88 | $7.30 | 432.65% | 149.54x | 173.26x | 7.59x | 6.11x | 2.52x | $20.38M | 1.04% | $321.86M | 6.38 | $1.96B | 67.00 | ||
| KRYS | KRYSTAL BIOTECH INC | $214.89 | $84.30 | 154.92% | 31.14x | 42.19x | 16.67x | 5.48x | 1.83x | $166.02M | 2.67% | $1.14B | 39.30 | $5.85B | 30.26 | ||
| VCYT | VERACYTE INC | $46.70 | $8.93 | 423.15% | 119.74x | 116.90x | 7.43x | 2.94x | 2.63x | $98.21M | 2.67% | $1.26B | 15.98 | $3.41B | 59.91 | ||
| HALO | HALOZYME THERAPEUTICS INC | $74.00 | $77.16 | -4.10% | 15.13x | 11.78x | 6.98x | 17.27x | 0.57x | $602.40M | 6.94% | $503.92M | 4.30 | $9.79B | 11.58 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.87 | $0.86 | 818.66% | 112.43x | 74.67x | 6.66x | 7.44x | 6.60x | $3.05M | 0.43% | $101.92M | 1.12 | $718.90M | 54.34 | ||
| CRMD | CORMEDIX INC | $9.82 | $16.68 | -41.11% | 4.33x | 4.63x | 3.48x | 2.07x | 1.09x | $74.42M | 9.98% | $374.13M | 4.93 | $874.14M | 7.79 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.50 | $42.09 | 31.86% | 20.40x | 18.27x | 3.44x | 1.76x | 0.79x | $832.13M | 7.81% | $6.06B | 31.54 | $10.01B | 12.95 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.86 | $2.32 | 196.28% | 25.41x | 46.70x | 4.39x | 7.75x | 3.51x | $21.15M | 3.86% | $70.68M | 0.89 | $486.24M | 21.43 | ||
| INCY | INCYTE CORP | $106.24 | $67.20 | 58.09% | 17.59x | 15.25x | 4.32x | 4.48x | 1.25x | $1.20B | 5.76% | $4.65B | 23.77 | $18.44B | 10.96 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $16.11 | $7.16 | 124.93% | 27.78x | 24.36x | 7.99x | 5.81x | 1.60x | $119.87M | 5.64% | $365.77M | 2.78 | $2.13B | 20.57 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $424.00 | $173.54 | 144.32% | 29.63x | 23.07x | 9.24x | 6.21x | 1.77x | $3.34B | 3.08% | $17.32B | 67.76 | $104.47B | 22.41 | ||
| EXEL | EXELIXIS INC | $42.25 | $27.35 | 54.48% | 17.17x | 17.63x | 4.96x | 5.24x | 1.22x | $779.77M | 6.88% | $2.16B | 8.05 | $11.13B | 12.00 | ||
| ADMA | ADMA BIOLOGICS INC | $18.32 | $9.33 | 96.42% | 20.82x | 30.27x | 8.95x | 10.11x | 1.65x | $40.73M | 0.93% | $431.19M | 1.81 | $4.37B | 25.40 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.27 | $39.81 | -11.40% | 10.92x | 10.80x | 2.46x | 2.43x | 0.63x | $296.89M | 14.63% | $835.12M | 14.51 | $1.55B | 5.76 | ||
| INVA | INNOVIVA INC | $21.29 | $18.26 | 16.58% | 11.26x | 17.89x | 3.78x | 1.58x | 1.11x | $196.54M | 13.37% | $1.01B | 14.63 | $1.37B | 6.39 | ||
| MNKD | MANNKIND CORP | $5.13 | $1.28 | 300.32% | 51.30x | 54.17x | 5.01x | -35.36x | 2.76x | $43.39M | 2.75% | -$44.55M | -0.15 | $1.81B | 24.70 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $761.45 | $351.04 | 116.92% | 17.52x | 17.81x | 5.54x | 2.59x | 2.96x | $4.22B | 5.35% | $30.96B | 298.82 | $80.23B | 14.04 | ||
| UTHR | UNITED THERAPEUTICS CORP | $477.20 | $194.65 | 145.16% | 16.76x | 16.99x | 6.68x | 3.12x | 6.48x | $1.12B | 5.37% | $6.59B | 150.46 | $19.21B | 10.83 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.51 | $10.90 | 115.73% | 13.13x | 15.81x | 4.99x | 3.14x | 22.17x | $234.54M | 8.14% | $920.25M | 7.51 | $2.20B | 6.80 | ||
| MDXG | MIMEDX GROUP INC | $6.78 | $3.17 | 113.86% | 24.21x | 15.64x | 2.55x | 4.20x | 1.66x | $66.82M | 6.65% | $238.95M | 1.61 | $880.26M | 12.72 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.